Johnson & Johnson (JNJ)
NYSE:JNJ
$161.98
-$3.24(-1.96%)
$162.65
$0.67(0.41%)
JNJJohnson & Johnson
$161.98
-$3.24 (-1.96%)

Johnson & Johnson Stock Analysis & Ratings

Johnson & Johnson Stock Analysis Overview

Smart Score
7
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Johnson & Johnson stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, Data-Driven rating system and does not include human intervention.

Stock Chart

JNJ
$161.98
-$3.24 (-1.96%)

JNJ Stock Stats

Previous Close$165.22
Open$163.27
Bid162 x 3
Ask162.75 x 190
Today’s Range$161.79 - $164.19
52-Week Range$133.65 - $173.65
Volume12.99M
Average Volume7.28M
Market Cap$426.56B
Beta0.71
P/E Ratio28.6
EPS5.66
Earnings DateJul 21, 2021
Dividend & Yield4.04 (2.49%)
Ex-Dividend DateMay 24, 2021

Company Description

Johnson & Johnson

Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Sector
Healthcare
Industry
Drug Manufacturers
CEO
Alex Gorsky
Employees
136,400
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, 08933, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

Johnson & Johnson News


JNJ FAQ

What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $133.65 and its highest was $173.65 in the past 12 months.
What is Johnson & Johnson’s market cap?
Johnson & Johnson’s market cap is $426.56B.
What is Johnson & Johnson’s price target?
The average price target for Johnson & Johnson is $191.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $201.00 ,the lowest forecast is $183.00. The average price target represents 17.92% Increase from the current price of $161.98.
What do analysts say about Johnson & Johnson?
Johnson & Johnson’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Jul 21, 2021 which is in 29 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Apr 20, 2021. The company reported $2.319 earnings per share for the quarter, missing the consensus estimate of $2.337 by -$0.018.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of $1.06 which represents an annual dividend yield of 2.49%. Johnson & Johnson’s last Quarterly dividend payment was on Jun 08, 2021. Johnson & Johnson’s upcoming ex-dividend date is May 24, 2021
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,630,000,000 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of $2.319 in its last earnings report, missing expectations of $2.337. Following the earnings report the stock price went up 2.4%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Among the largest hedge funds holding Johnson & Johnson’s share is Yacktman Asset Management LP. It holds Johnson & Johnson’s shares valued at 361M.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis